Membrane Chromatography Market worth $408 million by 2025 explored in latest Research

The benefits offered by membrane chromatography over conventional chromatography methods, increasing biopharmaceutical R&D, and increasing regulatory scrutiny on the cleaning validation of downstream purification processes are the major factors driving the growth of the membrane chromatography market.

The report Membrane Chromatography Market  is estimated to grow from USD 198 million in 2020 to USD 408 million by 2025, at a CAGR of 15.5% during the forecast period.

Ask For PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=151487196

Market Segmentation:-

Based on product, the membrane chromatography market is segmented into consumables and accessories. The consumables segment is further divided into capsules, cassettes, and cartridges; syringe filters; membrane discs and sheets; spin columns; filter plates; and other consumables (such as pipettes, syringes, vials, and collection plates).

The ion exchange membrane chromatography segment accounted for the largest share of the membrane adsorbers market in 2019. Advantages associated with ion exchange membrane chromatography such as reliability, accuracy and precision, high selectivity and speed, scalability, high separation efficiency, and low cost of consumables and disposables are supporting the growth of this segment.

The flow-through membrane chromatography segment accounted for the largest share of the membrane adsorbers market in 2019.

Based on end user, the global Membrane adsorbers marketis segmented into pharmaceutical and biopharmaceutical companies, CROs, and academic and research institutes.

Key Market Drivers: -
            1 Benefits offered by membrane chromatography over conventional chromatography techniques
            2 Increasing biopharmaceutical R&D
            3 Increasing regulatory scrutiny on the cleaning validation of downstream purification processes

Regional Analysis:

In 2019, North America accounted for the largest share of the global Membrane adsorbers market, followed by Europe.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=151487196

Key Market Players:-

The major companies in the global membrane chromatography market are Sartorius AG (Germany), Danaher Corporation (US), Merck Millipore (Germany), Thermo Fisher Scientific (US), and 3M Company (US).

Ophthalmic Lasers Market to Witness Steady Growth in the Near Future

High prevalence of ophthalmic disorders, rapid growth in geriatric population, technological advancements, increasing regulatory approvals for ophthalmic lasers, rising prevalence of chronic diseases such as diabetes, and increasing initiatives to control visual impairment are expected to drive the growth of the global ophthalmic lasers market in the coming years.               

The Ophthalmic Lasers Market is expected to reach USD 1,245.4 Million by 2021 from USD 970.2 Million in 2016, at a CAGR of 5.1% from 2016 to 2021.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=251971654

Market Segmentation:-

The global ophthalmic lasers market is segmented on the basis of product types, applications, end users, and regions.

Based on product type, the ophthalmic lasers market is categorized into femtosecond lasers, excimer lasers, Nd:YAG lasers, diode lasers, and others. The femtosecond lasers segment is expected to command the largest share of the global ophthalmic lasers market, by product type and is projected to grow at the highest CAGR during the forecast period.

Based on applications, the ophthalmology lasers market is segmented into refractive error correction, cataract removal, glaucoma treatment, diabetic retinopathy treatment, AMD treatment, and other applications. In 2016, the refractive error correction segment is expected to command the largest share of the global ophthalmic lasers market.

Based on end users, the ophthalmic lasers market is segmented into hospitals and clinics & ambulatory surgery centers (ASCs). The hospitals segment is projected to command the largest share of the global ophthalmic lasers market.

Key Market Drivers:-
            1 High Prevalence of Ophthalmic Disorders
            2 Rapid Growth in Geriatric Population
            3 Technological Advancements and Increasing Regulatory Approvals for Ophthalmic Lasers
            4 Rising Prevalence of Chronic Diseases Such as Diabetes
            5 Increasing Initiatives to Control Visual Impairment

Regional Analysis:-

Based on regions, the ophthalmology lasers market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America is expected to account for the largest share of the global ophthalmic lasers market.

Request for Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=251971654

Key Market Players:-

Alcon Laboratories, Inc. (U.S.), Abbott Medical Optics, Inc. (U.S.), Carl Zeiss Meditec AG (Germany), Bausch & Lomb Incorporated (U.S.), Ellex Medical Lasers Limited (Australia), Topcon Corporation (Japan), Ziemer Ophthalmic Systems AG (Switzerland), IRIDEX Corporation (U.S.), NIDEK Co., Ltd. (Japan), and Lumenis Ltd. (Israel) are some of the key players in the ophthalmic lasers market.

Which of the product segment will dominate the gene expression analysis market in future?

The major factors driving the growth of the gene expression analysis market include decreasing cost of sequencing, rising prevalence of cancer, growing application areas of genomics, and the availability of gene expression databases.

The global Gene Expression Analysis Market is expected to reach USD 4.9 billion by 2023 from USD 3.2 billion in 2018, at a CAGR of 8.8%.

Ask for  PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=156613968

Market Segmentation: -

On the basis of products and services, the global gene expression analysis market has been segmented into consumables (reagents, DNA chips), Instruments (PCR, NGS, Microarray, others), and services (gene expression profiling services, bioinformatics solutions). The consumables segment is estimated to command the largest share of the market in 2018 and is also projected to register the highest CAGR. The high growth in this segment can be attributed to the growing decreasing sequencing costs leading to increased adoption of sequencing and other gene expression analysis techniques.

Based on end user, the market has been segmented into pharmaceutical and biotechnology companies, academic institutes and research centers, and other end users. The pharmaceutical and biotechnology companies’ segment is expected to command the largest share of 54.8% of the market in 2018. The large share and high growth of this segment can be attributed to factors such as high volume of research studies involving gene expression analysis and huge capital for high end analysis instruments and consumables.

Regional Analysis: -

Geographically, North America is expected to dominate the global gene expression analysis market in 2018, while the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth in this region can be attributed to domestic manufacturing of sequencing systems, western partnerships to improve healthcare, high R&D intensity, government focus on cancer and other life science research, and flourishing bioresearch centers.

Request for  Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=156613968

Top Key Players:-

The major players operating in the gene expression analysis market include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), and Bio-Rad Laboratories, Inc. (US) are the key players in the gene expression analysis market. Other players involved in this market are F. Hoffmann-La Roche Ltd. (Switzerland), GE Healthcare (UK), Pacific Biosciences of California, Inc. (US), BGI (China), PerkinElmer (US), Agilent Technologies Inc. (US), and QIAGEN N. V. (Netherlands), among others.

Cone Beam Imaging Market to Progress at a Healthy CAGR in Coming Years

The growth of this market is primarily driven by the factors such as growing prevelance of dental disorders, increasing demand for the cosmetic dentistry and expanding applications of CBCT. In addition to this, new product launches and approvals, partnerships, agreements and collaborations among market players and are also providing impetus for the growth of this market. Moreover, acceptance of the CBCT systems in breast imaging and untapped emerging economies provide significant growth opportunities in the market. However, high cost of the CBCT systems may hinder the growth of this market during the forecast period.

The global CBCT/Cone Beam Imaging Market is expected to reach USD 801.2 Million by 2021 from USD 494.4 Million in 2016, at a CAGR of 10.1% during the forecast period (2016-2021)

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=226049013

Market Segmentation: -

In this report, the Global CBCT/cone beam imaging market is segmented on the basis of application, patient position, end user and region.

Based on end user, the CBCT/cone beam imaging market is segmented into hospitals, practices and academic and research institutes. The hospital segment is expected to account for the largest share of the CBCT/cone beam imaging market in 2016. However, private practices are expected to grow at highest CAGR during the forecast period.

Growing awareness of dental healthcare, growth in geriatric population (especially in Japan), increasing prevalence of orthopedic disorders, partnerships/collaborations among key players, growing medical tourism for dental services, improving healthcare infrastructure, and growing disposable incomes in emerging Asian economies (such as China and India) are some of the key factors fuelling the growth of this market.

Target Audience:

• Cone beam computed tomography (CBCT) manufacturers and suppliers
• Dental/ENT/orthopedic associations
• Dental imaging equipment manufacturers
• Dental/ENT/orthopedic clinics and hospitals
• Academic institutes and universities
• Medical device manufacturers
• Venture capitalists
• Research and consulting firms

Regional Analysis: -

Based on region, the CBCT/cone beam imaging market is segmented into North America, Europe, Asia and Rest of the World (RoW). In 2016, North America is expected to dominate the market, followed by Europe.

Request for  Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=226049013 

Top key Players: -

Some of key players in this market include Danaher Corporation (U.S.), Carestream Health, Inc. (a subsidiary of Onex Corporation) (Canada), Planmeca Group (Finland), Vatech Co., Ltd. (South Korea), Dentsply Sirona (U.S.), Cefla S.C. (Italy), J. Morita MFG. Corp (Japan), Asahi Roentgen IND.CO., LTD. (Japan), PreXion Corporation (Japan), and CurveBeam LLC (U.S.).

Top 10 Cellular Analysis Market: Trends and Developments

The major factors driving the growth of this market are the growing biotechnology and biopharmaceutical industries, introduction of technologically advanced cell analysis instruments, increasing incidence of infectious and chronic diseases and rising number of patients suffering from cancer, and increasing investments from various government associations & life sciences companies for cell biology research activities.

The Top 10 Cellular Analysis Market  is expected to reach USD 41.34 Billion by 2021 from USD 28.66 Billion in 2016, at a CAGR of 7.6% from 2016 to 2021.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=247924081

This report segments the top 10 cellular analysis market on the basis of technology, application, end user, and region. Based on technology, the top 10 cellular analysis market is segmented into cell imaging techniques, polymerase chain reaction (PCR), flow cytometry, cell counting, spectrophotometry, blotting, high-content screening, cell microarray, sample preparation technologies, and centrifugation. The cell imaging techniques segment is expected to dominate the top 10 cellular analysis market in 2016. The increasing number of cancer cases, rising investments in cell biology research, and introduction of technologically advanced cell imaging instruments for the morphological & anatomical examination of specific or group of cells are factors contributing to the growth of this segment.

On the basis of application, the top 10 cellular analysis market is segmented into biopharmaceutical applications, stem cell research, cancer research, instruments, tissue engineering & regenerative medicine, and other applications (in vitro diagnostics, organ cultures, virology, IVF, and genetic counselling). The biopharmaceutical application segment is expected to account for the largest share of the top 10 cellular analysis market in 2016. The large share of this segment is attributed to the increasing demand of cell analysis technologies in biomolecule isolation and growing demand of biopharmaceutical therapeutic agents for the treatment of various diseases such as cancer and diabetes.

On the basis of end user, the top 10 cellular analysis market is segmented into hospitals and diagnostic laboratories, cell banks, research laboratories and institutes, biotechnology and pharmaceutical companies, and other end users. The hospitals and diagnostic laboratories segment is expected to account for the largest share of the top 10 cellular analysis market in 2016. Some of the major factors driving the growth of this segment include the increasing incidence of chronic and infectious diseases and rising healthcare spending across the globe.

On the basis of region, the top 10 cellular analysis market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market in 2016. Growth in this regional segment is driven the technological advancements in cell biology instruments and improved biotechnology and pharmaceutical industries.

Request for  Sample Pages  :- https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=247924081

Key players in the top 10 cellular analysis market include Bio-Rad Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies (U.S.), Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), GE Healthcare (U.S.), Olympus Corporation (Japan), Tecan Group (Switzerland), and Nikon Instruments (Japan).

Label-free Detection Market to witness major growth in coming years

Growth in this market is largely driven by the introduction of technologically advanced products, a growing number of drug discovery programs through academic-industrial partnerships, and the high sensitivity of label-free technologies.

The global Label-free Detection Market size is estimated to be USD 431 million in 2020 and projected to reach USD 626 million by 2025, at a CAGR of 7.7%.

Ask for  PDF Brochure: – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32435593

Market Segmentation: -

On the basis of product & service, the label-free detection market is broadly segmented into instruments, consumables and software & services. The consumables segment is further segmented into biosensor chips, microplates and reagents & kits. In 2019, instruments accounted for the largest share of the label-free detection products market owing to the various technological advancements in label-free detection systems.

On the basis of technology, the market is categorized into five technology segments—surface plasmon resonance, bio-layer interferometry, differential scanning calorimetry, isothermal titration calorimetry, and other label-free detection technologies. The surface plasmon resonance segment accounted for the largest share in 2019, due to the high sensitivity of this technology and its wide usage in determining specificity, affinity, and kinetic parameters during the binding of macromolecules.

Key Market Drivers: –
1 Introduction of technologically advanced products
2 Growing number of drug discovery programs through academic-industrial partnerships
3 High sensitivity of label-free technologies

Regional Analysis: -

In 2019, Asia Pacific region accounted for the fastest growing region of the label-free detection market. It is also estimated to grow at the highest CAGR in the label-free detection market during the forecast period, this is mainly due to the rising awareness, increasing government support and funding, and growth in life science research.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=32435593

Top Key Players: -

Some of the leading players in the label-free detection market include Danaher (US), Sartorius AG (Germany), Waters Corporation (US), PerkinElmer Inc. (US), AMETEK, Inc. (US), HORIBA Ltd. (Japan), Spectris (UK), METTLER TOLEDO (US), Corning Incorporated (US), and Agilent Technologies, Inc. (US)

 

Burn Care Market to witness major growth in coming years

 Market growth can be attributed to factors such as rising incidence of burns, increasing healthcare expenditure, favorable government initiatives, increasing number of emergency centers and burn units, and growing awareness regarding treatment options.

The global Burn Care Market is expected to reach USD 2.33 Billion by 2021 from USD 1.68 Billion in 2016, at a CAGR of 6.8% from 2016 to 2021.

Ask for  PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=247121470

Market Segmentation:-               

In this report, the burn care market has been segmented on the basis of product, depth of burn, end user, and region. Based on product, the market is segmented into advanced burn care, biologics, traditional burn care, and other burn care products. The advanced burn care products segment includes alginate dressings, collagen dressings, hydrogel dressings, hydrocolloid dressings, wound contact layers, film dressings, and foam dressings.

Based on the depth of burn, the burn care market is segmented into minor, partial-thickness, and full-thickness burns. The partial-thickness burns segment is expected to account for the largest share in 2016, owing to the increasing usage of advanced dressings and biologics such as skin grafts and substitutes.

On the basis of end users, the burn care market is segmented into hospitals, physician clinics, home care and other end users. The hospitals segment is expected to account for the largest share of the global burn care market in 2016.

Key market Drivers: –
1 Rising Incidence of Burn Injuries
2 Advancements in Burn Care Products
3 Rising Awareness on Burn Care
4 Increasing Healthcare Expenditure

Regional Analysis:-

Based on regions, the burn care market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market in 2016.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=247121470

Top key Players: -

Key players in the burn care market include Smith & Nephew plc (U.K.), Mölnlycke Health Care (Sweden), Convatec Inc. (U.K.), Acelity L.P. (U.S.), Coloplast A/S (Denmark), Derma Sciences, Inc. (U.S.), Medtronic (Ireland), and 3M Company (U.S.).

Nucleic Acid Isolation and Purification Market to Witness Steady Growth in the Near Future

The growth of this market can mainly be attributed to the increasing R&D activities as well as technological advancements and increasing automation. On the other hand, the high cost of automated instruments is expected to hinder the growth of the market.

The Nucleic Acid Isolation and Purification Market  is projected to reach USD 4.8 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 8.9% during the forecast period.

Ask for PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=229978287

Objectives of the Study

• To define, describe, and forecast the global nucleic acid isolation and purification market by product, method, type, application, end user, and region
• To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, and opportunities)
• To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall nucleic acid isolation and purification market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
• To forecast the size of the nucleic acid isolation and purification market in four major regions along with their respective key countries (North America, Europe, Asia Pacific, and the Rest of the World)
• To profile the key players in the global nucleic acid isolation and purification market and comprehensively analyze their core competencies and market shares
• To track and analyze competitive developments such as product launches, expansions, and R&D activities of the leading players in the nucleic acid isolation and purification market

Market Segmentation: -

On the basis of product, the DNA isolation and purification market has been segmented into kits, reagents, and instruments. The kits segment accounted for the largest share of the global nucleic acid isolation and purification market in 2019.

On the basis of application, the global nucleic acid isolation market is segmented into diagnostics, drug discovery & development, personalized medicine, agriculture & animal research, and other applications.

On the basis of type, the global DNA isolation and purification market is segmented into plasmid DNA isolation and purification, total RNA isolation and purification, circulating nucleic acid isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR cleanup, and other nucleic acid isolation and purification types.

Regional Analysis: -

In 2019, North America accounted for the largest share of the nucleic acid isolation and purification market, followed by Europe. The large share of this region can be attributed to factors such as significant R&D spending in biotechnology and pharmaceutical companies, the large size of the biotechnology industry, technological advancements, and government support in the region.

Request for Sample Pages : – https://www.marketsandmarkets.com/requestsampleNew.asp?id=229978287

Key Players: -

QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (US), and F. Hoffmann-La Roche Ltd. (Switzerland) are the key players operating in the nucleic acid isolation market.

US Outpatient Surgical Procedures Market is expected to reach 144 million procedures by 2023

The growing number of outpatient surgeries is expected to increase the adoption of capnography monitoring devices in outpatient surgical departments in the US.

The US Outpatient Surgical Procedures Market is expected to grow from ~129 million procedures in 2018 to ~144 million procedures by 2023, at a CAGR of 2.1% during the forecast period.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94756744

The dental surgeries segment is expected to command the largest share of the overall outpatient surgical procedures market in the US during the forecast period.

By type, the dental surgeries segment accounted for the largest share of the US outpatient surgical procedures market in 2018. The large share of this market segment can be attributed to the large number of dental surgeries performed in physicians’ offices in the US, which require minimal sedation.

The other surgeries segment is expected to grow at the highest CAGR during the forecast period.

Other surgeries performed in outpatient departments include surgeries of the nervous system (laminectomy and excision of the intervertebral disc and decompression of the peripheral nerve), endocrine system (partial or complete thyroidectomy), and integumentary system (mastectomy and lumpectomy).

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=94756744

Growth in this market segment can largely be attributed to the increasing prevalence of disorders of the intervertebral disc, peripheral nerves, and glands as well as growth in the burden of breast cancer.

CT Scanner Market: Trends and Developments

Factors like growing need for effective and early diagnosis, rising global prevalence of targeted, increasing preference for minimally invasive diagnostic procedures, increasing benefits of CT scans, and technological advancements are driving the growth of the market            

The Global CT Scanner Market is projected to reach USD 6.20 Billion by 2022, at a CAGR of 5.4% during the forecast period.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=184364345  

Cone beam CT technology segment poised to grow fastest in CT scanner market.

On the basis of technology, the CT scanners market is segmented into high-slice CT, mid-slice CT, low-slice CT, and cone beam CT technology. The cone beam CT technology segment is expected to grow faster than the other segments during the forecast period, majorly due to factors like procedural advantages; rising market demand for cosmetic dentistry; and ongoing product development & commercialization across major healthcare markets.

Portable CT scanners segment expected to register fastest growth rate in the forecast period.

Based on type, the CT scanners market is divided into stationary and portable CT scanners. Portable CT scanners segment is poised to grow faster than the other segment due to increasing number of device installations across major markets, growing application horizons, and the lower switching costs provided by portable CT scanners.

North America accounted for the largest share of the CT scanner market

Geographically, the CT scanner market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2017, which is primarily driven by growth in the aging U.S. population; an increasing public emphasis on minimally invasive & effective disease management strategies; robust reimbursement scenario; increasing adoption of novel applications; and rising public-private investments.

Request for Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=184364345

The major players in the CT scanner market are Koninklijke Philips N.V. (Netherlands), GE Healthcare (U.S.), Toshiba Corporation (Japan), Siemens AG (Germany), Hitachi Ltd. (Japan), Shimadzu Corporation (Japan), Samsung Electronics Co., Ltd. (South Korea), Neusoft Medical Systems Co., Ltd. (China), Medtronic plc (Ireland), Shenzhen Anke High-tech Co., Ltd. (Hong Kong), Accuray Incorporated (U.S.), PlanMED (Finland), Koning Corporation (U.S.), Carestream Health Inc. (U.S.), and PointNix Co. Ltd (South Korea).

 

Healthcare Interoperability Solutions Market: Trends and Developments

The major factors driving the growth of this market include the growing need to curb increasing healthcare costs and a growing focus on patient-centric care delivery. Moreover, government initiatives for enhancing patient care & safety and government funding for healthcare interoperability are also boosting market growth.

The Healthcare Interoperability Solutions Market is expected to reach USD 4.2 billion by 2024 from an estimated USD 2.3 billion in 2019, at a CAGR of 12.6%.

Ask for  PDF Brochure: – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=17705847

Market Segmentation:-

Based on type, the healthcare interoperability solutions market is segmented into software and services. The services segment is estimated to account for the largest market share in 2019. The large share of this segment can be attributed to the shifting era towards cloud computing and reduced operational costs for better and faster performance of business processes and applications.

Based on software type, the Interoperability solutions Market is segmented into EHR interoperability solutions, lab system interoperability solutions, imaging system interoperability solutions, HIE interoperability solutions, enterprise interoperability solutions, and other interoperability solutions. The HIE interoperability solutions segment is expected to grow at the highest CAGR during the forecast period.

Recent Developments:-

• In 2018, Epic launched the One Virtual System Worldwide, and added new features to its Care Everywhere solution.
• In 2016 Cerner opened a Health center at the Cerner Center in Bangalore, India, which helped the company enter the Indian market and also expand its geographic reach.
• In 2017, Epic launched its Share Everywhere.
• In 2016, Cerner launched its Open Developer Experience (code).

Regional Analysis:-

North America is expected to account for the largest share of the Interoperability solutions Market in 2019, followed by Europe. The dominance of the North American region can be attributed to the rising demand for quality healthcare delivery, a need to curb increasing healthcare expenditure, and the implementation of favorable initiatives & regulations to improve the overall efficiency of healthcare organizations in the region.

Request for  Sample pages :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=17705847  

Top Key Players:-

The prominent players in the Interoperability solutions Market are Cerner Corporation (US), Infor, Inc. (US), Allscripts Healthcare Solutions, Inc. (US), Koninklijke Philips NV (Netherlands), InterSystems Corporation (US), Orion Health Group Limited (New Zealand), iNTERFACEWARE (Canada), Quality Systems, Inc. (US), OSP Labs (US), Epic Systems Corporation (US), ViSolve, Inc. (US), and Jitterbit (US).

Report explores the Animal Growth Promoters and Performance Enhancers Market worth $18.5 billion by 2024

The growth of this market is primarily driven by the increasing global meat demand, research into alternatives to antibiotics, and the need to deal with epidemics and environmental factors. However, various countries have stringent regulations in place against antibiotics and particular growth promoters, which has affected their adoption.

The report Animal Growth Promoters and Performance Enhancers Market  is projected to reach USD 18.5 billion by 2024 from an estimated USD 13.9 billion in 2019, at a CAGR of 5.9% during the forecast period.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137134167

Market Segmentations: -.

Based on type, the animal growth promoters market is segmented into antibiotic and non-antibiotic growth promoters. The non-antibiotic growth promoters segment accounted for the largest share of the animal growth promoters and performance enhancers market in 2018.

On the basis of animal type, the Animal Performance Enhancers Market is segmented into poultry, swine, livestock, aquaculture, and other farm animals (equine, rabbit, camel, deer, yak, and geese). In 2019, the poultry segment accounted for the largest share of the animal growth promoters and performance enhancers market.

Critical questions answered in the Report: -

• How will the current animal growth promotion trends affect the market in the long term?
• What are the reasons contributing to the growth of the non-antibiotic growth promoters segment in the market?
• Which regions are likely to grow at the highest CAGR?
• What are the challenges hindering the adoption of equipment in the market?
• What are the growth strategies being implemented by major market players?

Regional Analysis: -

In 2019, the Asia Pacific region accounted for the largest market share of 36.7%, followed by North America (26.1%) in 2018. The largest share of the Asia Pacific region is attributed to the strong animal products industry in this region, high population (generating greater domestic meat demand), a comparatively relaxed regulatory scenario, and government efforts to encourage animal producers.

Request for Sample Pages : - https://www.marketsandmarkets.com/requestsampleNew.asp?id=137134167

Key Players: -

The key players in the global animal performance enhancers market are Merck and Co. Inc. (US), Cargill Inc. (US), Royal DSM N.V. (Germany), Vetoquinol (France), Bupo Animal Health (SA), Elanco Animal Health Inc. (US), CHR Hansen (UK), Novus International Inc. (US), Associated British Foods (ABF) plc (UK), Alltech Inc. (US), ERBER AG (UK), Archer-Daniels-Midland Company (US), Phibro Animal Health Corporation (US), Kemin Industries (US), SHV (Nutreco) (UK), BASF SE (UK), Lallemond Inc. (Canada), Bluestar Adisseo Company (France), Evonik Industries AG (UK), and Land O Lake Inc.(US).